(Q33924634)

30 July 2017

1 reference

title

Autoimmune and antitumor consequences of antibodies against antigens shared by normal and malignant tissues (English)

1 reference

30 July 2017

Livingston PO

1

1 reference

30 July 2017

Ragupathi G

series ordinal

2

1 reference

30 July 2017

Musselli C

series ordinal

3

1 reference

30 July 2017

publication date

1 March 2000

1 reference

30 July 2017

number of pages

9

1 reference

Journal of Clinical Immunology

inferred from page(s)

published in

1 reference

30 July 2017

volume

20

1 reference

30 July 2017

issue

2

1 reference

30 July 2017

page(s)

85-93

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1006697728855

30 July 2017

exact match

0 references

cites work

GD3 vaccines for melanoma: superior immunogenicity of keyhole limpet hemocyanin conjugate vaccines

1 reference

12 December 2020

Immune sera and monoclonal antibodies define two configurations for the sialyl Tn tumor antigen.

1 reference

12 December 2020

Immunotoxins containing Pseudomonas exotoxin that target LeY damage human endothelial cells in an antibody-specific mode: relevance to vascular leak syndrome

1 reference

12 December 2020

Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia

1 reference

12 December 2020

Ganglioside conjugate vaccines. Immunotherapy against tumors of neuroectodermal origin

1 reference

12 December 2020

Cell surface expression of paraneoplastic encephalomyelitis/sensory neuronopathy-associated Hu antigens in small-cell lung cancers and neuroblastomas

1 reference

12 December 2020

Selection of tumor antigens as targets for immune attack using immunohistochemistry: II. Blood group-related antigens

1 reference

12 December 2020

A new era for cancer immunotherapy based on the genes that encode cancer antigens

1 reference

12 December 2020

Phase I clinical trial in cancer patients of a new monoclonal antibody FC-2.15 reacting with tumor proliferating cells

1 reference

12 December 2020

Use of rituximab, the new FDA-approved antibody.

1 reference

12 December 2020

Epidermal growth factor receptor gene expression in estrogen receptor-positive and negative human breast cancer cell lines

1 reference

12 December 2020

Natural autoantibodies constitute a substantial part of normal circulating immunoglobulins

1 reference

12 December 2020

Cell-mediated autoimmunity in paraneoplastic neurological syndromes with anti-Hu antibodies.

1 reference

12 December 2020

Ganglioside expression on human malignant melanoma assessed by quantitative immune thin-layer chromatography.

1 reference

12 December 2020

Immunogenicity of melanoma-associated gangliosides in cancer patients

1 reference

12 December 2020

Differential responses of human tumor cell lines to anti-p185HER2 monoclonal antibodies

1 reference

12 December 2020

Serological response of melanoma patients receiving melanoma cell vaccines. I. Autologous cultured melanoma cells

1 reference

12 December 2020

Immunogenicity of synthetic TF-KLH (keyhole limpet hemocyanin) and sTn-KLH conjugates in colorectal carcinoma patients

1 reference

12 December 2020

Immunogenicity of a fucosyl-GM1-keyhole limpet hemocyanin conjugate vaccine in patients with small cell lung cancer.

1 reference

12 December 2020

Prolonged survival for melanoma patients with elevated IgM antibody to oncofetal antigen

1 reference

12 December 2020

Coexpression of GD3 ganglioside with CD45RO in resting and activated human T lymphocytes.

1 reference

12 December 2020

Monoclonal antibody therapy of cancer

1 reference

12 December 2020

Monoclonal antibodies to epithelium-specific components of the human milk fat globule membrane: Production and reaction with cells in culture

1 reference

12 December 2020

Selection of tumor antigens as targets for immune attack using immunohistochemistry: I. Focus on gangliosides.

1 reference

12 December 2020

Molecular cloning and expression of human tumor-associated polymorphic epithelial mucin

1 reference

12 December 2020

Expression of potential target antigens for immunotherapy on primary and metastatic prostate cancers.

1 reference

12 December 2020

Carbohydrate vaccines that induce antibodies against cancer. 2. Previous experience and future plans

1 reference

12 December 2020

Serological identification of human tumor antigens

1 reference

12 December 2020

Phase 1 trial of immunological adjuvant QS-21 with a GM2 ganglioside-keyhole limpet haemocyanin conjugate vaccine in patients with malignant melanoma

1 reference

12 December 2020

Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. German Cancer Aid 17-1A Study Group

1 reference

12 December 2020

Active specific immunotherapy of a murine mammary adenocarcinoma using a synthetic tumor-associated glycoconjugate.

1 reference

12 December 2020

CAMPATH-1H monoclonal antibody in therapy for previously treated low-grade non-Hodgkin's lymphomas: a phase II multicenter study. European Study Group of CAMPATH-1H Treatment in Low-Grade Non-Hodgkin's Lymphoma

1 reference

12 December 2020

Active Immunization of Human Ovarian Cancer Patients Against a Common Carcinoma (Thomsen-Friedenreich) Determinant Using a Synthetic Carbohydrate Antigen

1 reference

12 December 2020

Selection of tumor antigens as targets for immune attack using immunohistochemistry: protein antigens

1 reference

12 December 2020

Differential apomucin expression in normal and neoplastic human gastrointestinal tissues

1 reference

12 December 2020

GM2-KLH conjugate vaccine: increased immunogenicity in melanoma patients after administration with immunological adjuvant QS-21

1 reference

12 December 2020

Characterization of IgG and IgM antibodies induced in melanoma patients by immunization with purified GM2 ganglioside

1 reference

12 December 2020

Paraneoplastic neurologic syndromes: pathogenesis and physiopathology

1 reference

12 December 2020

Approaches to Augmenting the Immunogenicity of Melanoma Gangliosides: From Whole Melanoma Cells to Ganglioside‐KLH Conjugate Vaccines

1 reference

12 December 2020

Improved survival in stage III melanoma patients with GM2 antibodies: a randomized trial of adjuvant vaccination with GM2 ganglioside

1 reference

12 December 2020

Induction of antibodies against GD3 ganglioside in melanoma patients by vaccination with GD3-lactone-KLH conjugate plus immunological adjuvant QS-21.

1 reference

12 December 2020

The serologic response of patients with stage II melanoma to allogeneic melanoma cell vaccines

1 reference

12 December 2020

Phase I trial of the murine monoclonal anti-GD2 antibody 14G2a in metastatic melanoma

1 reference

12 December 2020

Antibodies against autologous tumor cell proteins in patients with small-cell lung cancer: association with improved survival

1 reference

12 December 2020

Immunization of breast cancer patients using a synthetic sialyl-Tn glycoconjugate plus Detox adjuvant

1 reference

12 December 2020

Antibodies against GD2 ganglioside can eradicate syngeneic cancer micrometastases.

1 reference

12 December 2020

Vaccination of high-risk breast cancer patients with mucin-1 (MUC1) keyhole limpet hemocyanin conjugate plus QS-21.

1 reference

12 December 2020

Sialosyl-Tn. A novel mucin antigen associated with prognosis in colorectal cancer patients

1 reference

12 December 2020

Antibodies against mucin-associated sialyl-Tn epitopes correlate with survival of metastatic adenocarcinoma patients undergoing active specific immunotherapy with synthetic STn vaccine

1 reference

12 December 2020

Ganglioside GD2 specific monoclonal antibody 3F8: a phase I study in patients with neuroblastoma and malignant melanoma

1 reference

12 December 2020

Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival.

1 reference

12 December 2020

Randomized phase II study of BR96-doxorubicin conjugate in patients with metastatic breast cancer

1 reference

12 December 2020

Carbohydrate vaccines in cancer: immunogenicity of a fully synthetic globo H hexasaccharide conjugate in man.

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1006697728855

1 reference

Dimensions Publication ID

30 July 2017

1029104995

0 references

Fatcat ID

release_qvh25bou3zemtpc27hwe6t76uu

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/qvh25bou3zemtpc27hwe6t76uu

24 November 2022

mapped directly with Wikidata item

1 reference